Signaling through the small G-protein Cdc42 is involved in insulin-like growth factor-I resistance in aging articular chondrocytes

Journal of Orthopaedic Research

Volumn 24, Issue 8, 2006, Pages 1765-1772

  Fortier, Lisa A ^a   Miller, Brian J ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Aging; Articular chondrocytes; Cdc42; Insulin like growth factor I; Signaling

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATE; PROTEIN CDC42; RAC PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SOMATOMEDIN C;

AGING; ANIMAL CELL; ARTICLE; CARTILAGE CELL; CELL AGING; CELL ISOLATION; CONTROLLED STUDY; DRUG TARGETING; EXTRACELLULAR MATRIX; HORSE; MOLECULAR MECHANICS; NEWBORN; NONHUMAN; NORTHERN BLOTTING; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AGING; ANIMALS; CARTILAGE; CDC42 GTP-BINDING PROTEIN; CHONDROCYTES; DOWN-REGULATION; HORSES; INSULIN-LIKE GROWTH FACTOR I; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 33746956085     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20185     Document Type: Article

References (43)

1. Shetlar MR, Masters YF. 1955. Effect of age on polysaccharide composition of cartilage. Proc Soc Exp Biol Med 90:31-33.
2. Eichelberger L, Roma M. 1954. Effects of age on the histochemical characterization of costal cartilage. Am J Physiol 178:296-304.
3. Carrington JL. 2005. Aging bone and cartilage: cross-cutting issues. Biochem Biophys Res Commun 328:700-708.
4. Hadley EC, Lakatta EG, Morrison-Bogorad M, et al. 2005. The future of aging therapies. Cell 120:557-567.
5. Lombard DB, Chua KF, Mostoslavsky R, et al. 2005. DNA repair, genome stability, and aging. Cell 120:497-512.
6. Campisi J. 2005. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120: 513-522.
7. Carlo MD Jr, Loeser RF. 2003. Increased oxidative stress with aging reduces chondrocyte survival: correlation with intracellular glutathione levels. Arthritis Rheum 48:3419-3430.
8. Matsushita T, Fukuda K, Yamazaki K, et al. 2004. Hypoxia-induced nitric oxide protects chondrocytes from damage by hydrogen peroxide. Inflamm Res 53:344-350.
9. Yudoh K, Nguyen T, Nakamura H, et al. 2005. Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res Ther 7:R380-R391.
10. Martin JA, Klingelhutz AJ, Moussavi-Harami F, et al. 2004. Effects of oxidative damage and telomerase activity on human articular cartilage chondrocyte senescence. J Gerontol A Biol Sci Med Sci 59:324-337.
11. Martin JA, Buckwalter JA. 2003. The role of chondrocyte senescence in the pathogenesis of osteoarthritis and in limiting cartilage repair. J Bone Joint Surg Am 85-A(Suppl 2):106-110.
12. Campisi J. 2003. Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes. Exp Gerontol 38:5-11.
13. Ashton IK, Matheson JA. 1979. Change in response with age of human articular cartilage to plasma somatomedin activity. Calcif Tiss Int 29:89-94.
14. Martin JS, Ellerbrock SM, Buckwalter JA. 1997. Age-related decline in chondrocyte response to insulin-like growth factor-I: the role of growth factor binding proteins. J Orthop Res 15:491-498.
15. Loeser RF, Shanker G, Carlson CS, et al. 2000. Reduction in the chondrocyte response to insulin-like growth factor 1 in aging and osteoarthritis: studies in a non-human primate model of naturally occurring disease. Arthritis Rheum 43:2110-2120.
16. Middleton J, Manthey A, Tyler J. 1996. Insulin-like growth factor (IGF) receptor, IGF-I, interleukin-1β (IL-1β), and IL-6 mRNA expression in osteoarthritic and normal human cartilage. J Histochem Cytochem 44:133-141.
17. McQuillan DJ, Handley CJ, Campbell MA, et al. 1986. Stimulation of proteoglycan biosynthesis by serum and insulin-like growth factor-1 in cultured bovine articular cartilage. Biochem J 240:423-430.
18. Tyler JA. 1985. Chondrocyte-mediated depletion of articular cartilage proteoglycans in vitro. Biochem J 225:493-507.
19. Denko CW, Boja B, Moskowitz RW. 1994. Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis - insulin, insulin-like growth factor-I, growth hormone. J Rheumatol 21:1725-1730.
20. Wang E, Wang J, Chin E, et al. 1995. Cellular patterns of insulin-like growth factor system gene expression in murine chondrogenesis and osteogenesis. Endocrinology 136:2741-2751.
21. Posever J, Phillips FM, Pottenger LA. 1995. Effects of basic fibroblast growth factor, transforming growth factor-B1, insulin-like growth factor-1, and insulin on human osteoarthritic articular cartilage explants. J Orthop Res 13:832-837.
22. Fortier LA, Deak MM, Semevolos SA, et al. 2004. Insulin-like growth factor-I diminishes the activation status and expression of the small GTPase Cdc42 in articular chondrocytes. J Orthop Res 22:436-445.
23. Jin G, Sah RL, Li Y-S, et al. 2000. Biomechanical regulation of matrix metalloproteinase-9 in cultured chondrocytes. J Orthop Res 18:899-908.
24. Schwartz M. 2004. Rho signalling at a glance. J Cell Sci 117:5457-5458.
25. Fortier LA, Kornatowski MA, Mohammed HO, et al. 2005. Age related changes in serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and articular cartilage structure in Thoroughbred horses. Equine Vet J 37:37-42.
26. Mankin HJ. 1968. The effect of aging on articular cartilage. Bull N Y Acad Med 44:545-552.
27. Nixon AJ, Lust G, Vernier-Singer M. 1992. Isolation, propagation and cryopreservation of equine articular chondrocytes. Am J Vet Res 53:2364-2370.
28. Rao J, Otto WR. 1992. Fluorimetric DNA assay for cell growth estimation. Anal Biochem 207:186-192.
29. Bobacz K, Erlacher L, Smolen J, et al. 2004. Chondrocyte number and proteoglycan synthesis in the aging and osteoarthritic human articular cartilage. Ann Rheum Dis 63:1618-1622.
30. Taylor SJ, Shalloway D. 1996. Cell cycle-dependent activation of Ras. Curr Biol 6:1621-1627.
31. Bernard V, Bohl BP, Bokoch GM. 1999. Characterization of Rac and Cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases. J Biol Chem 274:13198-13204.
32. Etienne-Manneville S, Hall A. 2002. Rho GTPases in cell biology. Nature 420:629-635.
33. Bernards A. 2003. GAPS galore! A survey of putative Ras superfamily GTPase activating proteins in man and Drosophila. Biochim Biophys Acta 1603:47-82.
34. Moon SY, Zheng Y. 2003. Rho GTPase-activating proteins in cell regulation. Trends Cell Biol 13:13-22.
35. Smith GR, Givan SA, Cullen P, et al. 2002. GTPase-activating proteins for Cdc42. Eukaryot Cell 1:469-480.
36. Alexander K, Yang HS, Hinds PW. 2004. Cellular senescence requires CDK5 repression of Rac1 activity. Mol Cell Biol 24:2808-2819.
37. Tsukamoto K, Hirano K, Yamashita S, et al. 2002. Retarded intracellular lipid transport associated with reduced expression of Cdc42, a member of Rho-GTPases, in human aged skin fibroblasts: a possible function of Cdc42 in mediating intracellular lipid transport. Arterioscler Thromb Vasc Biol 22:1899-1904.
38. Parekh VV, Falcone JC, Wills-Frank LA, et al. 2004. Protein kinase B, P34cdc2 kinase, and p21 ras GTP-binding in kidneys of aging rats. Exp Biol Med 229:850-856.
39. Tavera C, Abribat T, Reboul P, et al. 1996. IGF and IGF-binding protein system in the synovial fluid of osteoarthritic and rheumatoid arthritic patients. Osteoarthritis Cart 4:263-274.
40. Olney RC, Tsuchiya K, Wilson DM, et al. 1996. Chondrocytes from osteoarthritic cartilage have increased expression of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 (IGFBP-3) and -5, but not IGF-II or IGFBP-4. J Clin Endocr Metab 81:1096-1103.
41. Dore S, Pelletier J, DiBattista JA, et al. 1994. Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation: possible role of IGF-1 binding proteins. Arthritis Rheum 37:253-263.
42. Chevalier X, Tyler JA. 1996. Production of binding proteins and role of the insulin-like growth factor I binding protein 3 in human articular cartilage explants. Br J Rheumatol 35:515-522.
43. Verschure PJ, Van Noorden CJF, van Marle J, et al. 1996. Articular cartilage destruction in experimental inflammatory arthritis: insulin-like growth factor-1 regulation of proteoglycan metabolism in chondrocytes. Histochem J 28:835-857.